Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q2 EPS of ($0.03), $0.09 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $20.09 million versus the consensus estimate of $12.45 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.